Element Capital Management’s Niagen Bioscience NAGE Stock Holding History

Element Capital Management’s Portfolio NAGE Stock Details NAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-36,860	Closed	-$155K	–	1030
2018 Q1	$155K	Buy	+36,860	New	+$193K	﹤0.01%	728
2017 Q4	–	Sell	-32,351	Closed	-$139K	–	170
2017 Q3	$139K	Sell	32,351 -103,950	-76%	-$380K	0.06%	43
2017 Q2	$521K	Buy	+136,301	New	+$432K	0.11%	34

Other funds holding NAGE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JMPWA

JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Element Capital Management's NAGE Position: Q2 2018 in Review

Element Capital Management sold out of Niagen Bioscience (NAGE) in Q2 2018, closing a stake of 36,860 shares — an estimated $155K sold.

Element Capital Management first reported a position in NAGE in Q2 2017 and held it in 3 quarters. The position peaked at $521K in Q2 2017. 64 funds tracked by Wall St. Rank hold NAGE as of Q2 2018.

Element Capital Management reported no remaining Niagen Bioscience position as of Q2 2018 after selling out during the quarter.
Element Capital Management sold 36,860 Niagen Bioscience shares in Q2 2018, an estimated $155K.
Element Capital Management first reported a position in Niagen Bioscience in Q2 2017 and held it in 3 quarters.
Element Capital Management's Niagen Bioscience position peaked at $521K in Q2 2017.
64 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2018.

Based on Element Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.